好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Infections of the Nervous System

Sunday 04/29/07
09:00 AM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Full-Day Course
Allen J. Aksamit, Jr., MD, FAAN
Participants should be able to better recognize the characteristics of brain abscess and its treatment, diagnose and treat neuropathy of leprosy, treat fungal infections and HIV disease of the nervous system, recognize prion disorders, and be alert to emerging infections and their neurological complications.
No CME available
Medical Knowledge
Advanced
Practitioner, Fellow, Academician, Resident
Event Timeline
09:00 AM - 09:40 AM Brain Abscess
Russell E. Bartt, MD, FAAN
09:45 AM - 10:25 AM Neuroimaging of CNS Infections
Kelly Koeller, MD
10:30 AM - 10:45 AM Break
10:45 AM - 11:25 AM Leprosy
Thomas R. Swift, MD, FAAN
11:30 AM - 12:10 PM Fungal Infections
John R. Perfect, MD
12:15 PM - 01:30 PM Lunch
01:30 PM - 02:10 PM Emerging Infectious Diseases
James J. Sejvar, MD, FAAN
02:15 PM - 02:55 PM Prion Disorders
Michael D. Geschwind, MD, PhD, FAAN
03:00 PM - 03:40 PM HIV of CNS and PNS
Avindra Nath, MD, MBBS, FAAN
03:45 PM - 04:00 PM Break
04:00 PM - 04:40 PM Case Studies in Neurological Infections
Allen J. Aksamit, Jr., MD, FAAN
Faculty Disclosures
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Allen J. Aksamit, Jr., MD, FAAN Dr. Aksamit has nothing to disclose.
Russell E. Bartt, MD, FAAN Dr. Bartt has nothing to disclose.
Kelly Koeller, MD No disclosure on file
Thomas R. Swift, MD, FAAN No disclosure on file
John R. Perfect, MD No disclosure on file
Avindra Nath, MD, MBBS, FAAN The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
James J. Sejvar, MD, FAAN Dr. Sejvar has nothing to disclose.